P-521 Phase II trial evaluating combination, weekly gemcitabineand docetaxel in progressive, chemotherapy-exposed NSCLC: Preliminary results of OPN 003
2005
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI